Olympus’ shares plunge following FDA warning letter over manufacturing failures

The FDA issued a warning letter to Olympus following inspections at six of the company's international manufacturing sites completed in late 2025, citing manufacturing failures. The warning triggered a sharp decline in Olympus' share price, signaling regulatory enforcement action against a major medical device supplier.